These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34814099)

  • 61. Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients.
    Ye BS; Seo SW; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Chin J; Jeon S; Lee JM; Seong JK; Kim JS; Lee JH; Choe YS; Lee KH; Sohn YH; Ewers M; Weiner M; Na DL
    Alzheimers Dement; 2015 May; 11(5):494-503.e3. PubMed ID: 25048578
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals.
    Pettigrew C; Soldan A; Zhu Y; Cai Q; Wang MC; Moghekar A; Miller MI; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M
    Neurobiol Aging; 2020 Apr; 88():33-41. PubMed ID: 31932050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Banning LCP; Ramakers IHGB; Köhler S; Bron EE; Verhey FRJ; de Deyn PP; Claassen JAHR; Koek HL; Middelkoop HAM; van der Flier WM; van der Lugt A; Aalten P; ;
    Am J Geriatr Psychiatry; 2020 Jul; 28(7):735-744. PubMed ID: 32088096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment.
    Romero-Sevilla R; Casado-Naranjo I; Portilla-Cuenca JC; Duque-de San Juan B; Fuentes JM; Lopez-Espuela F
    Curr Alzheimer Res; 2018; 15(7):671-678. PubMed ID: 29357793
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cortical thickness, white matter hyperintensities, and cognition after stroke.
    Dickie DA; Gardner K; Wagener A; Wyss A; Arba F; Wardlaw JM; Dawson J;
    Int J Stroke; 2020 Jan; 15(1):46-54. PubMed ID: 31088224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study.
    Schmidt R; Fazekas F; Kapeller P; Schmidt H; Hartung HP
    Neurology; 1999 Jul; 53(1):132-9. PubMed ID: 10408549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
    JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
    Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM
    Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 73. White matter hyperintensity burden in elderly cohort studies: The Sunnybrook Dementia Study, Alzheimer's Disease Neuroimaging Initiative, and Three-City Study.
    Ramirez J; McNeely AA; Scott CJM; Masellis M; Black SE;
    Alzheimers Dement; 2016 Feb; 12(2):203-210. PubMed ID: 26208292
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholinergic dysfunction, neurodegeneration, and amyloid-beta pathology in neurodegenerative diseases.
    Petrova T; Orellana C; Jelic V; Oeksengaard AR; Snaedal J; Høgh P; Andersen BB; Naik M; Engedal K; Wahlund LO; Ferreira D
    Psychiatry Res Neuroimaging; 2020 Aug; 302():111099. PubMed ID: 32505903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Age Moderates Associations of Hypertension, White Matter Hyperintensities, and Cognition.
    Guevarra AC; Ng SC; Saffari SE; Wong BYX; Chander RJ; Ng KP; Kandiah N
    J Alzheimers Dis; 2020; 75(4):1351-1360. PubMed ID: 32417773
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions.
    Jeong HW; Her M; Bae JS; Kim SK; Lee SW; Kim HK; Kim D; Park N; Chung WT; Lee SY; Choe JY; Kim IJ
    Rheumatol Int; 2015 May; 35(5):861-9. PubMed ID: 25315702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
    Canevelli M; Adali N; Cantet C; Andrieu S; Bruno G; Cesari M; Vellas B;
    J Neurol; 2013 Jul; 260(7):1859-65. PubMed ID: 23504051
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
    Robinson JL; Corrada MM; Kovacs GG; Dominique M; Caswell C; Xie SX; Lee VM; Kawas CH; Trojanowski JQ
    Acta Neuropathol; 2018 Sep; 136(3):377-388. PubMed ID: 29916037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.